Foresee Pharmaceuticals Co Ltd (6576) — Financial Flexibility Index
Foresee Pharmaceuticals Co Ltd (6576) has a Financial Flexibility Index of -0.25x as of June 2025. Free cash flow of NT$-151.26 Million (operating CF NT$-157.53 Million minus capex NT$6.26 Million) represents 0% of total liabilities (NT$593.99 Million). Check 6576 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Foresee Pharmaceuticals Co Ltd Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Foresee Pharmaceuticals Co Ltd across 8 annual periods. See Foresee Pharmaceuticals Co Ltd (6576) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Foresee Pharmaceuticals Co Ltd (2017–2024)
Year-by-year free cash flow to debt coverage for Foresee Pharmaceuticals Co Ltd. For the full company profile including market capitalisation, see Foresee Pharmaceuticals Co Ltd market capitalisation.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.82x | NT$-1.02 Billion | NT$-1.17 Billion | NT$560.15 Million | ▼ -33.2% |
| 2023 | -1.36x | NT$-841.27 Million | NT$-887.55 Million | NT$616.93 Million | ▼ -206.3% |
| 2022 | -0.45x | NT$-175.16 Million | NT$-233.22 Million | NT$393.43 Million | ▲ +30.5% |
| 2021 | -0.64x | NT$-205.69 Million | NT$-213.33 Million | NT$321.26 Million | ▲ +73.2% |
| 2020 | -2.39x | NT$-646.61 Million | NT$-674.80 Million | NT$270.40 Million | ▲ +24.9% |
| 2019 | -3.19x | NT$-361.29 Million | NT$-447.82 Million | NT$113.40 Million | ▲ +10.5% |
| 2018 | -3.56x | NT$-448.33 Million | NT$-462.43 Million | NT$125.99 Million | ▲ +23.9% |
| 2017 | -4.68x | NT$-465.18 Million | NT$-483.10 Million | NT$99.44 Million | — |